🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this Phase 2, open-label, multicenter, non-randomized pilot stu...
Status
Active Not Recruiting
Location
Hospital Germans Trials i Pujol
Start Date
2023-09-21
Trial ID
NCT05849610
Treatments Being Tested
Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Start Date
2019-01-03
Trial ID
NCT03829371
Treatments Being Tested
The purpose of this study is to compare the efficacy of GR1803 Injection wi...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2026-03-09
Trial ID
NCT07452198
Treatments Being Tested
This is a single-arm, phase II, open-label trial to investigate the effects...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2021-09-10
Trial ID
NCT04782687
Treatments Being Tested
Autoimmune encephalitis is an autoimmune disease of the central nervous sys...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2024-11-08
Trial ID
NCT06867991
This research study is being done to compare the efficacy and safety of the...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07247097
The purpose of this study is to compare the efficacy (rate of very good par...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-05-31
Trial ID
NCT03871829
This is a multicenter, single arm, open-label, Phase 2 study in mutiple mye...
Status
Unknown
Location
Innsbruck Medical University
Start Date
2023-11-23
Trial ID
NCT06189833
Treatments Being Tested
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bis...
Status
Recruiting
Location
Clovis Community Medical Center
Start Date
2021-10-04
Trial ID
NCT05020236
Treatments Being Tested
The purpose of this study is to look at the safety, tolerability, and serum...
Status
Recruiting
Location
University of Maryland Greenebaum Comprehensive Cancer Center
Start Date
2025-10-23
Trial ID
NCT07075510
Treatments Being Tested